What is the optimal management of high risk, clinically localized prostate cancer? Academic Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms

abstract

  • There are no randomized trials comparing RP to radiotherapy for any risk category. In high-risk prostate cancer patients, both approaches have potential benefits and cumulative toxicities that must be matched to disease characteristics and patient expectations in selecting a treatment course.

publication date

  • September 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2009.12.012

PubMed ID

  • 20816616

Additional Document Info

start page

  • 557

end page

  • 67

volume

  • 28

number

  • 5